Search
Advanced Search
Toggle navigation
Home
Journals & eBooks
Browse Journals by Subject
Browse Journals by Title
Browse Patent Journals
Free Online Samples
Journals Impacting Science
New Titles 2020
New Titles 2019
Price and Ordering Information
Subscription Rates 2020
Subscription Rates 2019
eBooks Website
Browse eBooks by Subject
Browse eBooks by Title
Browse Video Books
Journals and eBooks Catalog
Free Online Trials
Endorsements
Articles by Disease
Bentham Online
Accessibility Of Content
Bentham Insight
Online Feedback
Purchase Articles
Search Articles
Social Media
Submit Manuscripts
Marketing Opportunities
Advertise With Us
Journals and eBooks Catalog
Media-Pack-2019
Author's Benefits Guide
Events by Region
Events by Subject Areas
Exhibit Schedule
Healthcare Industry Resources
Kudos
Media Partners
Partnering Events
Promotional Services
For Librarians
FAQs for e-prints/reprints
Journal Catalog 2019
Journal Catalog 2020
Library Recommendations
Order Bulk ePrints
Order Bulk Reprints
Table of Contents Alert
Trial Requests
For Authors & Editors
Author Benefits
Author Reprints
Author's Benefits Guide
Copyediting Services
Editorial Policies
General FAQs
Guidelines for Guest Editors
Manuscript Transfer Facility
Online Manuscript Submission
Journal Catalog 2019
Journal Catalog 2020
Publication Cycle - Process Flowchart
Publishing Ethics
Peer Review
Self-Archiving Policies
Table of Contents Alert
Contact Us
Current Cancer Drug Targets
Volume 19, 11 Issues, 2019
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access
Impact Factor:
2.72
5 Year Impact Factor:
3.238
Ranking and Category
135
th
of
229
in
Oncology
Order Your Article Before Print
Join as Executive Guest Editor
Become a Reviewer
Join Editorial Board
Submit Book Proposal
Thematic Issue Proposal
Submit Abstract Online
Contents
Current Cancer Drug Targets
,
Volume 12
- Number 9
Acknowledgement
,
12
(
9
):
i
- iii
DOI:
10.2174/1568009611209000i
Permissions
Order Reprints
Order Eprints
Editorial
Editorial [Hot Topic: Recent Advances in the Prevention and Therapy of Hepatocellular Carcinoma]
,
12
(
9
):
1043
- 1044
Anupam Bishayee
DOI:
10.2174/15680096112091043
View Editorial
Permissions
Download Free
mTOR as a Potential Target for the Prevention and Treatment of Hepatocellular Carcinoma
,
12
(
9
):
1045
- 1061
Laura Elisa Buitrago-Molina and Arndt Vogel
DOI:
10.2174/15680096112091045
View Abstract
Permissions
Order Reprints
Order Eprints
View Abstract
Targeted Therapy for Liver Cancer: Updated Review in 2012
,
12
(
9
):
1062
- 1072
Masatoshi Kudo
DOI:
10.2174/15680096112091062
View Abstract
Permissions
Order Reprints
Order Eprints
View Abstract
Non-Coding RNAs as Therapeutic Targets in Hepatocellular Cancer
,
12
(
9
):
1073
- 1080
Chiara Braconi and Tushar Patel
DOI:
10.2174/15680096112091073
View Abstract
Permissions
Order Reprints
Order Eprints
View Abstract
Cancer Stem Cell as a Potential Therapeutic Target in Hepatocellular Carcinoma
,
12
(
9
):
1081
- 1094
Roberta W.C. Pang and Ronnie T.P. Poon
DOI:
10.2174/15680096112091081
View Abstract
Permissions
Order Reprints
Order Eprints
View Abstract
Angiogenesis in Hepatocellular Carcinoma: A Potential Target for Chemoprevention and Therapy
,
12
(
9
):
1095
- 1118
Anupam Bishayee and Altaf S. Darvesh
DOI:
10.2174/15680096112091095
View Abstract
Permissions
Order Reprints
Order Eprints
View Abstract
Role of Acyclic Retinoid in the Chemoprevention of Hepatocellular Carcinoma: Basic Aspects, Clinical Applications, and Future Prospects
,
12
(
9
):
1119
- 1128
Masahito Shimizu, Kenji Imai, Koji Takai and Hisataka Moriwaki
DOI:
10.2174/15680096112091119
View Abstract
Permissions
Order Reprints
Order Eprints
View Abstract
Prevention of Hepatocellular Carcinoma: Potential Targets, Experimental Models, and Clinical Challenges
,
12
(
9
):
1129
- 1159
Yujin Hoshida, Bryan C. Fuchs and Kenneth K. Tanabe
DOI:
10.2174/15680096112091129
View Abstract
Permissions
Order Reprints
Order Eprints
View Abstract
Role of NF-κB in Hepatocarcinogenesis and Its Potential Inhibition by Dietary Antioxidants
,
12
(
9
):
1160
- 1172
Howard Perry Glauert
DOI:
10.2174/15680096112091160
View Abstract
Permissions
Order Reprints
Order Eprints
View Abstract
Chemoprevention of Hepatocarcinogenesis with Dietary Isoprenic Derivatives: Cellular and Molecular Aspects
,
12
(
9
):
1173
- 1190
Thomas Prates Ong, Monica Testoni Cardozo, Aline de Conti and Fernando Salvador Moreno
DOI:
10.2174/15680096112091173
View Abstract
Permissions
Order Reprints
Order Eprints
View Abstract
Dietary Phytochemicals in the Chemoprevention and Treatment of Hepatocellular Carcinoma: In Vivo Evidence, Molecular Targets, and Clinical Relevance
,
12
(
9
):
1191
- 1232
Anupam Bishayee, Roslin J. Thoppil, Abhijeet Waghray, Jaclyn A. Kruse, Nicholas A. Novotny and Altaf S. Darvesh
DOI:
10.2174/15680096112091191
View Abstract
Permissions
Order Reprints
Order Eprints
View Abstract
Anti-tumor Efficacy of a Recombinant Human Arginase in Human Hepatocellular Carcinoma
,
12
(
9
):
1233
- 1243
Ariel K.M. Chow, Lui Ng, Hung Sing Li, Chi Wai Cheng, Colin S.C. Lam, Thomas C.C. Yau, Paul N.M. Cheng, Sheung Tat Fan, Ronnie T.P. Poon and Roberta W.C. Pang
DOI:
10.2174/15680096112091233
View Abstract
Permissions
Order Reprints
Order Eprints
View Abstract
Black Currant Anthocyanins Abrogate Oxidative Stress through Nrf2- Mediated Antioxidant Mechanisms in a Rat Model of Hepatocellular Carcinoma
,
12
(
9
):
1244
- 1257
Roslin J. Thoppil, Deepak Bhatia, Kendra F. Barnes, Erzsebet Haznagy-Radnai, Judit Hohmann, Altaf S. Darvesh and Anupam Bishayee
DOI:
10.2174/15680096112091244
View Abstract
Permissions
Order Reprints
Order Eprints
View Abstract
Editor-in-Chief
Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
USA
View Full Editorial Board
About the Journal
⇨ Journal Home
⇨ Editorial Policies
⇨ Editorial Board
⇨ Meet the Executive Guest Editor(s)
⇨ Board Recruitment Workflow
⇨ Join Editorial Board
⇨ Indexing Information
⇨ Announcements
⇨ Endorsements
⇨ Authors' Comments
For Authors
⇨ Author Guidelines
⇨ Animated Abstracts
⇨ Submit Abstracts Online
⇨ Submit Manuscripts Online
⇨ Open Access Funding
⇨ Publishing Ethics and Rectitude
⇨ Self-Archiving Policies
⇨ Manuscript Transfer Facility
For Guest Editors
⇨ Thematic Issue Proposal
⇨ Forthcoming Thematic Issues
⇨ Guest Editor Guidelines
For Reviewers
⇨ Reviewer Guidelines
⇨ Peer Review Workflow
⇨ Become a Reviewer
For Librarians & Readers
⇨ Contents & Abstracts
⇨ Open Access Articles
⇨ Free Copies Online
⇨ Thematic Issues
⇨ Journal Catalog 2019
⇨ Journal Catalog 2020
⇨ Most Accessed Articles
⇨ PURCHASE ARTICLES
⇨ Order Reprints
⇨ Subscribe
⇨ Trial Requests
⇨ Library Recommendation
Quick Links
⇨ Journal's New Website
⇨ Advertise with Us
⇨ Brand Ambassadors
⇨ Download PDF Flyer
⇨ Table of Contents Alert
Journal History
Current Cancer Drug Targets was launched in 2001. Dr. Ruiwen Zhang serves as the Editor-in-Chief of the journal.
Track Your Manuscript:
Enter Correct Manuscript Reference Number:
Submit Reference Number
Scopus CiteScore Metrics:
2.26
Related Journals
view more >>
Related eBooks
view more >>
eBooks Catalog
view eBooks Catalog >>
Webmaster Contact:
info@benthamscience.net
Copyright © 2019 Bentham Science
|
Privacy Policy